Financhill
Back

Qiagen NV Quote, Financials, Valuation and Earnings

Qiagen NV Price Quote

$42.65
+0.32 (+0.76%)
(Updated: November 22, 2024 at 12:45 PM ET)

Qiagen NV Key Stats

Sell
48
Qiagen NV (QGEN) is a Sell

Day range:
$42.04 - $42.48
52-week range:
$39.03 - $47.44
Dividend yield:
0%
P/E ratio:
27.74
P/S ratio:
4.71
P/B ratio:
2.67%

Volume:
960.3K
Avg. volume:
974.4K
1-year change:
1.76%
Market cap:
$9.4B
Revenue:
$2B
EPS:
$0.41

How Much Does Qiagen NV Make?

  • How Much Are Qiagen NV's Sales Annually?
    QGEN Revenues are $2B
  • How Much Profit Does Qiagen NV's Make A Year?
    QGEN net income is $341.3M

Is Qiagen NV Growing As A Company?

  • What Is Qiagen NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Qiagen NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.29%

Qiagen NV Stock Price Performance

  • Did Qiagen NV Stock Go Up Last Month?
    Qiagen NV share price went up by 0.5% last month
  • Did QGEN's Share Price Rise Over The Last Year?
    QGEN share price rose by 1.76% over the past 1 year

What Is Qiagen NV 52-Week High & Low?

  • What Is Qiagen NV’s 52-Week High Share Price?
    Qiagen NV has traded as high as $47.44 over the past 52 weeks
  • What Is Qiagen NV’s 52-Week Low Share Price?
    Qiagen NV has traded as low as $39.03 over the past 52 weeks

Qiagen NV Price To Free Cash Flow

Is It Risky To Buy Qiagen NV?

  • How Much Debt Does Qiagen NV Have?
    Total long term debt quarterly is $1.9B
  • How Much Cash Does Qiagen NV Have?
    Cash and short term investments quarterly total is $1.5B
  • What Is Qiagen NV’s Book Value Per Share?
    Book value per share is 15.88

Is Qiagen NV Cash Flow Positive?

  • What Is QGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $633.4M
  • What Is Qiagen NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $58.6M
  • What Is Qiagen NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$300.9M

Qiagen NV Return On Invested Capital

  • Is Management Doing A Good Job?
    QGEN return on invested capital is 1.8%
  • What Is Qiagen NV Return On Assets?
    ROA measures how assets are converting to revenues and is 1.57%
  • What Is QGEN Return On Equity?
    ROE is a measure of profitability and is 2.58%

Qiagen NV Earnings Date & Stock Price

  • What Is Qiagen NV's Stock Price Today?
    A single share of QGEN can be purchased today for 42.33
  • What Is Qiagen NV’s Stock Symbol?
    Qiagen NV trades on the nyse under the ticker symbol: QGEN
  • When Is Qiagen NV’s Next Earnings Date?
    The next quarterly earnings date for Qiagen NV is scheduled on February 6, 2025
  • When Is QGEN's next ex-dividend date?
    Qiagen NV's next ex-dividend date is January 30, 2024
  • How To Buy Qiagen NV Stock?
    You can buy Qiagen NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Qiagen NV Competitors

  • Who Are Qiagen NV's Competitors?
    Below is a list of companies who compete with Qiagen NV or are related in some way:
    • Boston Scientific Corp (BSX)
    • LENZ Therapeutics Inc (LENZ)
    • Merus NV (MRUS)
    • Oruka Therapeutics Inc (ORKA)
    • uniQure NV (QURE)

Qiagen NV Dividend Yield

  • What Is QGEN Dividend Yield?
    Qiagen NV’s dividend yield currently is 0%
  • What Is Qiagen NV’s Payout Ratio?
    Qiagen NV’s payout ratio is 0%
  • When Did Qiagen NV Last Pay A Dividend?
    The latest dividend pay date is November 22, 2024
  • What Is Qiagen NV’s Dividend Per Share?
    Qiagen NV pays a dividend of $0.00 per share

Qiagen NV Analyst Estimates

YoY Growth Past Surprise
EPS: 29.41% 3.81%
Revenue: 5.46% 2.19%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 50.59
Upside from Last Price: 19.5%

Major Shareholders

  • How many QGEN shares are owned by institutional investors?
    301.4M QGEN shares are owned by institutional investors
  • How many QGEN shares are owned by insiders?
    0 QGEN shares are owned by insiders